Preclinical Safety
Save
Preclinical Safety is a field of study that deals with the assessment of the safety of new drugs and other chemical substances before they are tested in humans. Preclinical safety studies are essential to identify any potential risks associated with a new drug or substance, and to determine the safe dosage and administration route for human testing.
Types of Preclinical Safety Studies
Preclinical safety studies can be divided into two main types: in vitro studies and in vivo studies. In vitro studies are conducted in the laboratory, using cells or tissues from animals or humans. In vivo studies are conducted in live animals, and are used to assess the safety and efficacy of a new drug or substance in a whole organism.
Preclinical safety studies typically include a battery of tests to assess the following:
- Acute toxicity: The potential for a new drug or substance to cause harm after a single exposure.
- Subchronic toxicity: The potential for a new drug or substance to cause harm after repeated exposure over a period of time.
- Chronic toxicity: The potential for a new drug or substance to cause harm after long-term exposure.
- Carcinogenicity: The potential for a new drug or substance to cause cancer.
- Reproductive toxicity: The potential for a new drug or substance to harm the reproductive system.
- Developmental toxicity: The potential for a new drug or substance to harm the developing fetus.
The Importance of Preclinical Safety Studies
Preclinical safety studies are essential to ensure the safety of new drugs and other chemical substances before they are tested in humans. These studies help to identify any potential risks associated with a new drug or substance, and to determine the safe dosage and administration route for human testing.
By conducting preclinical safety studies, researchers can help to prevent the occurrence of adverse events in humans, and ensure that new drugs and other chemical substances are safe for use.
